Search - tctmd.com

Displaying 421 - 440 of 699

Sort: Relevancy | Date

Presentation TCT 2016

TCT 374: Propensity Score Matched Analysis of Acute Kidney Injury Following Percutenous Coronary Intervention with Trans-Radial versus Trans-Femoral Approach

Presenter: Joseph P. Carrozza Jr, Charles J. Davidson

October 30, 2016

Presentation TCT 2016

TCT 546: Imaging and Physiology-Guided Zero Contrast Percutaneous Coronary Intervention in Advanced Chronic Kidney Disease

Presenter: Joseph P. Carrozza Jr, Charles J. Davidson

October 30, 2016

Presentation TCT 2016

Using Virtual Reality in Interventional Cardiology

Presenter: Oscar A. Mendiz, Giora Weisz, Silvio J. Bezerra

October 30, 2016

Presentation TCT 2016

A Percutaneous Shoehorn via Transbrachial Artery Approach in a Staggering Tavi Procedure With Edwards Sapien 3 Aortic Valve in a Patient With Extremely Calcified Aortic Valve

Presenter: Oscar A. Mendiz, Giora Weisz, Caterina Gandolfo

October 30, 2016

Presentation TCT 2016

Peri-Procedural Planning of Renal Sympathetic Denervation using the ReCor Paradise System

Presenter: Oscar A. Mendiz, Giora Weisz, Philipp Lurz

October 30, 2016

Presentation TCT 2016

LV Volume Reduction in Post-AMI, Ischemic Heart Failure Patients

Presenter: Oscar A. Mendiz, Giora Weisz, Horst Sievert

October 30, 2016

Presentation SOLACI 2016

Denervación Renal - Donde estamos hoy?

Presenter: Humberto Casal Pati?o

June 10, 2016

Presentation Fellows 2016

Renal Artery Interventions: Current State of the Field

Presenter: Sahil A. Parikh, Duane S. Pinto

April 17, 2016

Presentation ISET 2016

Renal Artery Stenting in Association with EVAR: Technical Considerations

Presenter: Marcelo Guimaraes

February 09, 2016

Presentation ISET 2016

Drug-Coated Balloons for Renal FMD

Presenter: Fabrizio Fanelli

February 09, 2016

Presentation

Quantifying the 3 Biases That Lead to Unintentional Overestimation of the Effect of Renal Denervation

Presenter: James P. Howard

January 11, 2016

Presentation TCT 2015

Contrast Nephropathy Clinical Trial Updates (AVERT, RenalGuard, Preserve, and Others)

Presenter: Somjot S. Brar, Richard Solomon, Roxana Mehran

October 15, 2015

Presentation TCT 2015

Featured Vascular Innovation Technologies 5: Denervation in Hypertensive Renal Transplantation Patients Verves Disruptive Nonvascular Catheter Option to Nephrectomy

Presenter: Greg L. Kaluza, Joachim Schofer, Richard R. Heuser

October 15, 2015

Presentation TCT 2015

Considerations Regarding Renal Function in the Patient With Atrial Fibrillation

Presenter: Gerhard C. Schuler, C. Michael Gibson

October 14, 2015

Presentation TCT 2015

TCT 90: Sustained Beneficial Effects of Multielectrode Renal Denervation on Cardiac Adaptations in Resistant Hypertension A 24-Month Follow-up Study

Presenter: Michael A. Weber, Stephen G. Worthley, Konstantinos Tsioufis

October 13, 2015

Presentation TCT 2015

TCT 89: Renal Sympathetic Denervation in Treatment-Resistant Essential Hypertension a Sham-Controlled, Double-blinded Randomized Trial (RESET trial)

Presenter: Michael A. Weber, Stephen G. Worthley, Ole Mathiassen

October 13, 2015

Presentation TCT 2015

TCT 88: Transcatheter Perivascular Chemical Neurolysis to Produce Renal Denervation Targeted, Local Delivery of Alcohol as a Viable Alternative to Radiofrequency Approaches

Presenter: Michael A. Weber, Stephen G. Worthley, Tim A. Fischell

October 13, 2015

Presentation TCT 2015

TCT 87: Noninvasive Renal Denervation Study Using Externally Delivered Focused Ultrasound in Severe Resistant Hypertension One-Year Follow-up Results

Presenter: Michael A. Weber, Stephen G. Worthley, Roland E Schmieder

October 13, 2015

Presentation TCT 2015

TCT 86: Safety and Performance of the Next-Generation EnligHTN Renal Denervation System in Patients With Drug-Resistant Hypertension 24-Month Results From a First-in-Human Multicentre Study

Presenter: Michael A. Weber, Stephen G. Worthley

October 13, 2015

Presentation TCT 2015

TCT 93: Improvement in Renal Function and Its Impact on All-Cause Mortality After Transcatheter Aortic Valve Replacement (TAVR) Experience From the PARTNER Trial

Presenter: Jeffrey J. Popma, Mathew Williams, Nirat Beohar

October 13, 2015

Advertisement

TCT 374: Propensity Score Matched Analysis of Acute Kidney Injury Following Percutenous Coronary Intervention with Trans-Radial versus Trans-Femoral Approach

TCT 546: Imaging and Physiology-Guided Zero Contrast Percutaneous Coronary Intervention in Advanced Chronic Kidney Disease

Using Virtual Reality in Interventional Cardiology

A Percutaneous Shoehorn via Transbrachial Artery Approach in a Staggering Tavi Procedure With Edwards Sapien 3 Aortic Valve in a Patient With Extremely Calcified Aortic Valve

Peri-Procedural Planning of Renal Sympathetic Denervation using the ReCor Paradise System

LV Volume Reduction in Post-AMI, Ischemic Heart Failure Patients

Denervación Renal - Donde estamos hoy?

Renal Artery Interventions: Current State of the Field

Renal Artery Stenting in Association with EVAR: Technical Considerations

Drug-Coated Balloons for Renal FMD

Quantifying the 3 Biases That Lead to Unintentional Overestimation of the Effect of Renal Denervation

Contrast Nephropathy Clinical Trial Updates (AVERT, RenalGuard, Preserve, and Others)

Featured Vascular Innovation Technologies 5: Denervation in Hypertensive Renal Transplantation Patients Verves Disruptive Nonvascular Catheter Option to Nephrectomy

Considerations Regarding Renal Function in the Patient With Atrial Fibrillation

TCT 90: Sustained Beneficial Effects of Multielectrode Renal Denervation on Cardiac Adaptations in Resistant Hypertension A 24-Month Follow-up Study

TCT 89: Renal Sympathetic Denervation in Treatment-Resistant Essential Hypertension a Sham-Controlled, Double-blinded Randomized Trial (RESET trial)

TCT 88: Transcatheter Perivascular Chemical Neurolysis to Produce Renal Denervation Targeted, Local Delivery of Alcohol as a Viable Alternative to Radiofrequency Approaches

TCT 87: Noninvasive Renal Denervation Study Using Externally Delivered Focused Ultrasound in Severe Resistant Hypertension One-Year Follow-up Results

TCT 86: Safety and Performance of the Next-Generation EnligHTN Renal Denervation System in Patients With Drug-Resistant Hypertension 24-Month Results From a First-in-Human Multicentre Study

TCT 93: Improvement in Renal Function and Its Impact on All-Cause Mortality After Transcatheter Aortic Valve Replacement (TAVR) Experience From the PARTNER Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content